Spectral is a Phase III company seeking U.S. FDA approval for its lead theranostics product for the treatment of septic shock. Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. Directed by the Company s Endotoxin Activity Assay EAA , the only FDA cleared diagnostic for the risk of developing sepsis, Spectral s EUPHRATES trial is the world s first theranostics trial in the area of sepsis.
Quote | Spectral Medical Inc (OTCMKTS:EDTXF)
Last: | $0.355 |
---|---|
Change Percent: | 0.0% |
Open: | $0.355 |
Close: | $0.355 |
High: | $0.355 |
Low: | $0.355 |
Volume: | 5,200 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Spectral Medical Inc (OTCMKTS:EDTXF)
116 patients enrolled June represents a new record breaking month for patient enrollment TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing ther...
TORONTO, June 07, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( "Spectral" or the "Company" ) (TSX: EDT) , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the results of its Annual Meeting of shareholders (the " Sha...
Message Board Posts | Spectral Medical Inc (OTCMKTS:EDTXF)
Subject | By | Source | When |
---|---|---|---|
If "winner" is the firm that people are | Lakersrback | investorshub | 11/20/2020 3:38:56 AM |
Ctso is the clear winner | Harbor6460 | investorshub | 11/18/2020 9:21:08 PM |
I love modest Canadian companies! | Lakersrback | investorshub | 11/03/2020 1:55:30 AM |
Mucho monkee business here. Very tightly held | Lakersrback | investorshub | 10/15/2020 6:02:16 PM |
Well I bought 20k shares at 0.50 this | eskay1954 | investorshub | 05/08/2020 10:22:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Spectral Medical Inc Company Name:
EDTXF Stock Symbol:
OTCMKTS Market:
Spectral Medical Inc Website:
116 patients enrolled June represents a new record breaking month for patient enrollment TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing ther...
TORONTO, June 07, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( "Spectral" or the "Company" ) (TSX: EDT) , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the results of its Annual Meeting of shareholders (the " Sha...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA. TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- S...